{"id":"po-azithromycin","safety":{"commonSideEffects":[{"effect":"Abdominal pain","drugRate":"2.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":100,"totalAffected":2,"trialsReporting":1},{"effect":"Nausea","drugRate":"1.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":100,"totalAffected":1,"trialsReporting":1},{"effect":"Vomiting","drugRate":"1.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":100,"totalAffected":1,"trialsReporting":1},{"effect":"Constipation","drugRate":"1.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":100,"totalAffected":1,"trialsReporting":1}]},"_chembl":{"chemblId":"CHEMBL4299381","moleculeType":"Small molecule","molecularWeight":"749.00"},"_sources":{"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (2 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T09:42:16.552047+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T06:21:46.316Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T09:42:23.237898+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT04287049","phase":"PHASE2","title":"A Study of Standard Drugs for Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-02-24","conditions":"Mycobacterium Avium Complex","enrollment":10},{"nctId":"NCT03672630","phase":"PHASE2, PHASE3","title":"Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease","status":"COMPLETED","sponsor":"Kevin Winthrop","startDate":"2019-02-22","conditions":"Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection","enrollment":474},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT03083197","phase":"PHASE4","title":"Scrub Typhus Antibiotic Resistance Trial","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2017-10-15","conditions":"Scrub Typhus","enrollment":177},{"nctId":"NCT07183462","phase":"PHASE4","title":"Azithromycin and Ampicillin for Late PPROM","status":"RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-10","conditions":"Pregnancy Complications, Infectious, Premature Birth, Neonatal Diseases and Abnormalities","enrollment":311},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT07213765","phase":"PHASE4","title":"Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease","status":"RECRUITING","sponsor":"Bin Cao","startDate":"2025-07-24","conditions":"Mycobacterium Avium Complex Pulmonary Disease","enrollment":188},{"nctId":"NCT07084402","phase":"PHASE4","title":"Short-term Bactericidal Effect of Contezolid in MAC-PD","status":"RECRUITING","sponsor":"Bin Cao","startDate":"2025-07-24","conditions":"Mycobacterium Avium Complex Pulmonary Disease","enrollment":188},{"nctId":"NCT06273891","phase":"PHASE3","title":"Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2024-03-08","conditions":"Premature Rupture of Membrane","enrollment":140},{"nctId":"NCT03273296","phase":"PHASE4","title":"Effect of Antibiotics on Gut Microbiome and Plasma Metabolome","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2017-10-15","conditions":"Microbial Colonization","enrollment":39},{"nctId":"NCT01556334","phase":"PHASE3","title":"Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes","status":"WITHDRAWN","sponsor":"Indiana University","startDate":"2010-04","conditions":"Preterm Premature Ruptured Membranes","enrollment":""},{"nctId":"NCT03060473","phase":"PHASE3","title":"Treatment of ppROM With Erythromycin vs. Azithromycin Trial","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2017-02-23","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":21},{"nctId":"NCT03431168","phase":"PHASE2","title":"A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-03-07","conditions":"HIV, Pregnancy Malaria, Sexually Transmitted Infection","enrollment":308},{"nctId":"NCT04458948","phase":"PHASE2","title":"Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2020-03-24","conditions":"COVID-19","enrollment":28},{"nctId":"NCT05971654","phase":"PHASE2, PHASE3","title":"Effect Of Azithromycin in Women at Risk of Preterm Labour","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"Preterm Labor","enrollment":200},{"nctId":"NCT04294069","phase":"PHASE4","title":"Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-09-14","conditions":"Preterm Premature Rupture of Membrane","enrollment":6},{"nctId":"NCT04336332","phase":"PHASE2","title":"Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-04-01","conditions":"SARS-CoV-2, COVID-19","enrollment":75},{"nctId":"NCT05596721","phase":"PHASE4","title":"Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-01-01","conditions":"Asthma, Chest Syndrome, Azithromycin","enrollment":248},{"nctId":"NCT04374903","phase":"NA","title":"Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2022-04-01","conditions":"COVID-19 Patients","enrollment":""},{"nctId":"NCT04339426","phase":"PHASE2","title":"Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2020-04-20","conditions":"Covid19","enrollment":3},{"nctId":"NCT04344444","phase":"PHASE3","title":"Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease","status":"TERMINATED","sponsor":"LCMC Health","startDate":"2020-04-13","conditions":"COVID-19","enrollment":22},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT01432080","phase":"PHASE2","title":"Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant","status":"TERMINATED","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2011-09","conditions":"Respiratory Tract Infections, Bronchiolitis Obliterans, Cryptogenic Organizing Pneumonia","enrollment":12},{"nctId":"NCT04381962","phase":"PHASE3","title":"A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-06-03","conditions":"COVID-19","enrollment":298},{"nctId":"NCT04349410","phase":"PHASE2, PHASE3","title":"The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol","status":"COMPLETED","sponsor":"The Camelot Foundation","startDate":"2020-04-11","conditions":"CoVid 19 Positive","enrollment":1800},{"nctId":"NCT04374552","phase":"PHASE2","title":"Asymptomatic COVID-19 Trial","status":"WITHDRAWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-05-05","conditions":"SARS-CoV-2 Infection","enrollment":""},{"nctId":"NCT04591600","phase":"PHASE1, PHASE2","title":"Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients","status":"COMPLETED","sponsor":"Alkarkh Health Directorate-Baghdad","startDate":"2020-07-01","conditions":"Covid19","enrollment":140},{"nctId":"NCT04575558","phase":"PHASE2","title":"HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19","status":"WITHDRAWN","sponsor":"Latin American Cooperative Oncology Group","startDate":"2020-06-30","conditions":"Sars-CoV2","enrollment":""},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT02024555","phase":"PHASE2","title":"Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2014-03","conditions":"Sarcoidosis; Antimycobacterial Therapy","enrollment":97},{"nctId":"NCT04454151","phase":"PHASE4","title":"Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-08-01","conditions":"Familial Adenomatous Polyposis","enrollment":10},{"nctId":"NCT04344457","phase":"PHASE1, PHASE2","title":"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19","status":"UNKNOWN","sponsor":"Perseverance Research Center, LLC","startDate":"2020-04-16","conditions":"COVID-19","enrollment":80},{"nctId":"NCT04441424","phase":"NA","title":"Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients","status":"COMPLETED","sponsor":"Alkarkh Health Directorate-Baghdad","startDate":"2020-04-03","conditions":"IMMUNOTHERAPY","enrollment":49},{"nctId":"NCT04363203","phase":"PHASE3","title":"VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)","status":"SUSPENDED","sponsor":"Salomeh Keyhani MD","startDate":"2020-04-30","conditions":"SARS-CoV-2, COVID-19","enrollment":300},{"nctId":"NCT04334382","phase":"PHASE3","title":"Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19","status":"UNKNOWN","sponsor":"Intermountain Health Care, Inc.","startDate":"2020-04-02","conditions":"COVID-19","enrollment":1550},{"nctId":"NCT02205255","phase":"PHASE3","title":"BACE Trial Substudy 2 - FarmEc Substudy","status":"COMPLETED","sponsor":"Wim Janssens","startDate":"2014-08-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":350},{"nctId":"NCT02205242","phase":"PHASE3","title":"BACE Trial Substudy 1 - PROactive Substudy","status":"COMPLETED","sponsor":"Wim Janssens","startDate":"2014-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":60},{"nctId":"NCT03278808","phase":"PHASE2","title":"Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis","status":"WITHDRAWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2018-09-17","conditions":"Malaria","enrollment":""},{"nctId":"NCT03249935","phase":"PHASE2","title":"YCFM (Youth Correctional Facilities Males)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-08-24","conditions":"Chlamydial Infection","enrollment":100},{"nctId":"NCT02135354","phase":"PHASE3","title":"Azithromycin for Acute Exacerbations Requiring Hospitalization","status":"TERMINATED","sponsor":"Wim Janssens","startDate":"2014-08-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":301},{"nctId":"NCT00319956","phase":"PHASE2","title":"Trial II of Lung Protection With Azithromycin in the Preterm Infant","status":"COMPLETED","sponsor":"Hubert Ballard","startDate":"2004-09","conditions":"Bronchopulmonary Dysplasia","enrollment":220},{"nctId":"NCT01307462","phase":"PHASE2","title":"Targeted Therapy of Bronchiolitis Obliterans Syndrome","status":"COMPLETED","sponsor":"Stephanie Lee","startDate":"2011-06","conditions":"Bronchiolitis Obliterans","enrollment":36},{"nctId":"NCT01379196","phase":"PHASE1, PHASE2","title":"Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy","status":"WITHDRAWN","sponsor":"Rabin Medical Center","startDate":"2011-05","conditions":"Graves Ophthalmopathy","enrollment":""},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT01915082","phase":"PHASE4","title":"Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-09","conditions":"Disorder Related to Lung Transplantation","enrollment":70},{"nctId":"NCT01103063","phase":"PHASE3","title":"Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa","status":"TERMINATED","sponsor":"Pfizer","startDate":"2010-10","conditions":"Intermittent Preventive Treatment In Pregnancy (IPTp)","enrollment":2891},{"nctId":"NCT01103713","phase":"PHASE3","title":"Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa","status":"TERMINATED","sponsor":"Pfizer","startDate":"2011-03","conditions":"Asymptomatic Parasitemia In Pregnancy","enrollment":168},{"nctId":"NCT00717561","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-02","conditions":"Pneumonia","enrollment":60},{"nctId":"NCT01921738","phase":"PHASE2","title":"The Effect of Azithromycin in the Treatment of Chronic Periodontitis","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2012-05","conditions":"Chronic Periodontitis","enrollment":80},{"nctId":"NCT00469274","phase":"NA","title":"Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2007-05","conditions":"Pertussis","enrollment":1102},{"nctId":"NCT01431248","phase":"","title":"PPROM Erythromycin Versus Azithromycin","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2011-09","conditions":"Preterm Premature Rupture of Membranes","enrollment":7},{"nctId":"NCT01169038","phase":"PHASE1","title":"Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-07","conditions":"Pulmonary Sarcoidosis, Lung Function","enrollment":15},{"nctId":"NCT01032174","phase":"","title":"Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-04","conditions":"Maxillary Sinusitis","enrollment":123},{"nctId":"NCT01032694","phase":"","title":"Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Pfizer","startDate":"2010-04","conditions":"Community-Acquired Pneumonia","enrollment":30},{"nctId":"NCT00821782","phase":"PHASE1","title":"Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2006-06","conditions":"Healthy Volunteer","enrollment":143},{"nctId":"NCT00392223","phase":"PHASE3","title":"Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne","status":"TERMINATED","sponsor":"Pfizer","startDate":"2007-10","conditions":"Acne Vulgaris","enrollment":118},{"nctId":"NCT00367653","phase":"PHASE3","title":"Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-11","conditions":"Malaria","enrollment":397},{"nctId":"NCT00153634","phase":"NA","title":"Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2004-03","conditions":"Cystic Fibrosis, Chronic Bronchitis","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":317,"structuredTrialResults":[{"hr":"","nctId":"NCT03249935","phase":"PHASE2","pValue":"","ciLower":"","ciUpper":"","endpoint":"Proportion of Participants Experiencing Treatment Failure After Treatment With Azithromycin for Uncomplicated Chlamydia Trachomatis (CT) in Males With and Without Urethral Symptoms","enrollment":100}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"PO azithromycin","genericName":"PO azithromycin","companyName":"Seattle Children's Hospital","companyId":"seattle-children-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":8,"withResults":2},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T09:42:23.237898+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}